SCHEMBL22119032

SCHEMBL22119032

O=c1[nH]c(C[C@H](Cl)Oc2ccc(CO)nc2)nc2c[nH]nc12

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ KDM5B Q9UGL1 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22119110 0.79 PTGES (0.31) —
SCHEMBL22118787 0.74 USP2 (0.30) —
SCHEMBL22118927 0.74 ADORA3 (0.33) —
SCHEMBL22119325 0.69 CYP1A2 (0.32) —
SCHEMBL22118823 0.66 KDM4E (0.42) —
SCHEMBL7422513 0.65 ADORA3 (0.33) —
SCHEMBL7419561 0.65 ADORA3 (0.33) —
SCHEMBL7379913 0.64 TNKS2 (0.50) —
SCHEMBL7348346 0.63 PNP (0.47) —
SCHEMBL2895609 0.60 MBOAT4 (0.42) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3897645-A1 DNA POLYMERASE IIIC INHIBITORS AND USE THEREOF Acurx Pharmaceuticals, LLC (US) 2021-10-27 — — EP disclosed
WO-2020132174-A1 DNA POLYMERASE IIIC INHIBITORS AND USE THEREOF ACURX PHARMACEUTICALS, LLC (US) 2020-06-25 — — WO disclosed
Send feedback